0001420506-16-000743.txt : 20160210
0001420506-16-000743.hdr.sgml : 20160210
20160210141955
ACCESSION NUMBER: 0001420506-16-000743
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20151231
FILED AS OF DATE: 20160210
DATE AS OF CHANGE: 20160210
EFFECTIVENESS DATE: 20160210
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHO CAPITAL PARTNERS INC
CENTRAL INDEX KEY: 0001020455
IRS NUMBER: 133087622
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-05883
FILM NUMBER: 161404877
BUSINESS ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 2127516677
MAIL ADDRESS:
STREET 1: 152 WEST 57TH STREET
STREET 2: 23RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: RHO MANAGEMENT CO INC
DATE OF NAME CHANGE: 19960806
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001020455
XXXXXXXX
12-31-2015
12-31-2015
false
RHO CAPITAL PARTNERS INC
152 WEST 57TH STREET
23RD FLOOR
NEW YORK
NY
10019
13F HOLDINGS REPORT
028-05883
N
Peter E. Kalkanis
Chief Financial Officer
2127516677
Peter E. Kalkanis, Chief Financial Officer
NEW YORK
NY
02-04-2016
0
9
290840
false
INFORMATION TABLE
2
Form13F_InfoTable.xml
INFORMATION TABLE FOR RHO CAPITAL PARTNERS INC
ANACOR PHARMACEUTICALS INC
COM
032420101
120640
1067892
SH
SOLE
1067892
0
0
CARA THERAPEUTICS INC
COM
140755109
44983
2668057
SH
SOLE
2668057
0
0
EVERYDAY HEALTH INC
COM
300415106
24727
4107522
SH
SOLE
4107522
0
0
INOTEK PHARMACEUTICALS CORP
COM
45780V102
29773
2627790
SH
SOLE
2627790
0
0
INTRALINKS HLDGS INC
COM
46118H104
57055
6290503
SH
SOLE
6290503
0
0
NEPHROGENEX INC
COM
640667101
1685
1052966
SH
SOLE
1052966
0
0
REACHLOCAL INC
COM
75525F104
4241
2570395
SH
SOLE
2570395
0
0
RUBICON PROJ INC
COM
78112V102
7676
466616
SH
SOLE
466616
0
0
XTERA COMMUNICATIONS INC
COM
98415E300
60
13366
SH
SOLE
13366
0
0